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Abstract Pyruvate dehydrogenase (PDH) and complex III are
two key protein complexes in mitochondrial metabolic activity.
Using a novel quantitative Western blotting method, we ¢nd
that PDH and complex III exist at a steady-state ratio of
1:100, 1:128 and 1:202 in HeLa cell extracts, ¢broblast mito-
chondria and heart tissue mitochondria, respectively. This di¡er-
ence in stoichiometry is re£ected in the immunogold labeling
intensities of the two complexes and by the much more sparse
distribution of PDH in £uorescence microscopy. In Rho0 ¢bro-
blasts there is a 64% reduction of complex III but the concen-
tration of PDH remains the same as wild-type.
3 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The full catalog of human genes is now known from auto-
mated genome analysis [1]. Newly developed proteomics ap-
proaches are identifying multiple gene products for many of
the genes related to alternative splicing and post-translational
modi¢cation [2,3]. Further, the cellular interactions of many
proteins are being revealed by two-hybrid and immunocapture
approaches in conjunction with proteomic analysis [4]. What
is currently missing from studies of cellular protein content is
quanti¢cation of the amounts of proteins in cells that can vary
by as much as 107-fold [5]. It will also be important to mea-
sure the changes in amounts of certain proteins that underlie
many normal cellular processes, as well as pathological con-
ditions.
Our studies are on the structure and functioning of mito-
chondria in human cells. Proteomics studies have identi¢ed
many of the proteins permanently or transiently a part of
the organelle [6,7]. These include the components of oxidative
phosphorylation (OXPHOS), other enzymes involved in en-
ergy metabolism such as components of the Krebs cycle, pro-
teins involved in mitochondrial DNA replication, as well as
transcription and translation of this DNA, and proteins in-
volved in apoptosis. To establish suitable methods for deter-
mining the amounts of speci¢c proteins, we have focused ini-
tially on two complexes involved in energy metabolism in
mitochondria, the pyruvate dehydrogenase complex (PDH)
and a respiratory chain complex ^ the ubiquinol cytochrome
c oxidoreductase (complex III). PDH is a large complex (Mr 8
million) involved in funneling pyruvate formed in glycolysis
into the Krebs cycle by conversion to acetyl CoA [8]. When
OXPHOS is inhibited or reduced by hypoxia and many other
conditions, PDH is inhibited and the glycolytically produced
pyruvate is converted to lactic acid by lactate dehydrogenase
[9]. Complex III is one of four complexes of the respiratory
chain. As the name implies, it transfers electrons from reduced
ubiquinone to cytochrome c [10] and is, therefore, at the cen-
ter of the respiratory chain, and its amount is a good measure
of respiratory chain content of cells. We have measured the
levels of these two protein complexes in three human cell
types ^ heart cells, ¢broblasts and HeLa cells. Adult heart
cells are fully di¡erentiated and rely almost exclusively on
OXPHOS for energy [11]. By contrast, cells in tissue culture,
such as primary ¢broblasts, and HeLas, which are cancer
cells, are rapidly dividing and use glycolysis almost exclusively
when grown in high glucose [12]. Therefore, we anticipate that
the levels of enzyme involved in energy metabolism will be
very di¡erent in these cell types.
We have used a novel quantitative Western blotting elec-
trophoresis approach. This method uses monoclonal antibod-
ies (mAbs) highly speci¢c to each protein to detect and quan-
tify them. The speci¢c antigenic protein, once over-expressed
and puri¢ed, is used as a calibration reference. To comple-
ment these measurements of amounts, we have examined the
distribution of both protein complexes by £uorescence and
electron microscopy (EM) techniques. These show the much
more sparse distribution of PDH compared with complex III,
consistent with the stoichiometry measurements.
2. Materials and methods
2.1. cDNA expression
Standard molecular biology procedures were carried out according
to Sambrook et al. [13] using Escherichia coli strain XL1 Blue (Stra-
tagene, La Jolla, CA, USA). cDNA sequences for human core 2 and
E1K were generated using a PCR ampli¢cation strategy from a quick-
clone human heart cDNA library (Clontech, Palo Alto, CA, USA).
Ampli¢cation using a 5P primer incorporates an in-frame N-terminal
six histidine tag, also both the 5P and 3P primers incorporate restric-
tion sites to facilitate subcloning into the NcoI and NdeI sites of the
E. coli expression vector pET15b (Novagen, Madison, WI, USA).
Inserts were fully sequenced by automated sequencing. The E1K se-
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quence encoded the known mature form of the protein and the core 2
sequence encoded the entire protein.
2.2. Expression and puri¢cation
E. coli strain BL-21 (DE3) (Novagen) was transformed with the
pET15b expression vectors containing the appropriate cDNA insert.
200 ml of cells in LB medium containing 50 Wg/ml ampicillin were
grown to an OD600 0.6. Protein expression was induced by addition of
IPTG to a ¢nal concentration of 1 mM. Cells were grown at 37‡C for
3 h. and then harvested by centrifugation. Cell pellets were resus-
pended in binding bu¡er (20 mM Tris^HCl, pH 7.9, 50 mM NaCl,
5 mM imidazole) and sonicated for 5 min. After sonication, the cells
were spun at 5000Ug. In both cases expressed protein was found in
the pellet after this low-speed spin, indicating its presence in inclusion
bodies. These inclusion bodies were solubilized in binding bu¡er sup-
plemented with 6 M guanidine and incubated on ice for 1 h. After
centrifugation at 20 000Ug, the target proteins were found in the
supernatant based on SDS^PAGE analysis. This supernatant was
applied to a Ni-NTA column that had been pre-equilibrated with
binding bu¡er. The column was washed with 10 volumes of binding
bu¡er followed by 15 volumes of wash bu¡er (20 mM Tris^HCl, pH
7.9, 50 mM NaCl, 60 mM imidazole). The bound protein was eluted
in fractions with 10 volumes of elution bu¡er (10 mM Tris^HCl, pH
7.9, 25 mM NaCl, 500 mM imidazole).
2.3. Dialysis and protein concentration determination
The elution fractions were analyzed by SDS^PAGE and those con-
taining the highest concentration of pure protein were selected for
dialysis. This was done using Spectra/Por dialysis tubing MWCO
3500 (Spectrum, CA, USA) using a sample volume ratio of 1:1000
of dialysis bu¡er (20 mM Tris^HCl, pH 7.9, 50 mM NaCl, 0.1% SDS)
for 5 h; this procedure was performed twice to ensure complete re-
moval of imidazole. Isolated protein concentration was then deter-
mined by the method of Gill and von Hippel [14], measuring absor-
bance at 280 nm as a function of the extinction coe⁄cient of the
protein based on its Trp, Tyr and Cys content.
2.4. Sample preparation
Protein concentrations were measured by the BCA method (Pierce,
Rockford, IL, USA). Mitochondria from bovine heart were puri¢ed
according to Smith [15]. Human heart mitochondria were prepared by
Analytical Biological Services (Wilmington, DE, USA) also according
to Smith. HeLa cells were cultured and counted using a hemocytom-
eter.
2.5. SDS^PAGE and quantitative Western blotting
Gel electrophoresis was performed according to Laemmli in a 15%
gel [16]. For Western blotting, samples were transferred in CAPS
bu¡er from gels to polyvinylidene di£uoride membranes (0.45 Wm
pore size, Millipore, Bedford, MA, USA) [17]. All antibodies were
diluted to 1 Wg/ml. Primary antibodies to core 2, E1K and the second-
ary biotinylated goat anti-mouse secondary antibody were obtained
from Molecular Probes (Eugene, OR, USA). Reactive secondary anti-
bodies were detected by streptavidin conjugated to the £uorescent
probe Alexa Fluor-488 (Molecular Probes). Fluorescence was detected
using the STORM scanning system (Molecular Dynamics, Sunnyvale,
CA, USA).
2.6. Immunogold transmission electron microscopy (TEM)
Bovine heart tissue was obtained within 90 min post mortem. Tis-
sue was minced and ¢xed in 0.1% glutaraldehyde/4% paraformalde-
hyde in 0.1 M sodium phosphate bu¡er for 2 h. Tissue was washed
twice in bu¡er, 15 min per wash, to remove ¢xative, and washed once
for 15 min in bu¡er plus 50 mM glycine. Samples were then incubated
in 5% gelatin for 15 min at 37‡C. Gelatin was solidi¢ed at 0‡C and
blocks were placed in 2.3 M sucrose in bu¡er overnight at 4‡C with
rotation. Tissue blocks were then placed on sectioning pins and
plunge-frozen in liquid nitrogen.
Cryosections were prepared by the method of Liou et al. [18] using
a Reichert-Jung Ultracut microtome with F4E cryo-attachment,
placed on 400 mesh nickel grids and incubated on 2% gelatin at
37‡C for 20 min. Sections were washed four times with 0.15% glycine
in 0.14 M NaCl, 3 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH
7.4 (PBS) and then blocked in 5% bovine serum albumin for 15 min.
Primary antibodies were diluted to 60 Wg/ml in PBS and incubated
with sections for 3 h. After washing four times in the same bu¡er,
sections were incubated with 5 or 10 nm gold-conjugated GAM sec-
ondary antibodies (Amersham, Buckinghamshire, UK) diluted 1:20 in
PBS for 30 min. After four additional washings in PBS, antigen^anti-
body complexes were stabilized by incubation with 1% glutaralde-
hyde, 5 min. Sections were washed seven times in double distilled
H2O and counterstained with a 0.4% uranyl acetate^2% methyl cellu-
Fig. 1. Western blot quanti¢cation of the PDH protein, E1K, and the complex III protein, core 2, in human heart and ¢broblast mitochondrial
preparations and within a de¢ned number of cultured human cells. The proteins core 2 (A) and E1K (B) were detected by Western blot in 38
Wg, 76 Wg of HeLa cells, 40 Wg of Rho0 mitochondria, 40 Wg of MRC5 wild-type mitochondria, 2 Wg and 5 Wg of human heart mitochondria.
The density of the detected band is then compared to that of increasing amounts of the respective puri¢ed recombinant protein (the ¢rst eight
columns). These band densities were converted to pmol concentrations and are represented as a histogram below.
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lose solution, and then viewed on a Philips CM12 TEM at 80 kV.
Image analysis of scanned negatives was performed using NIH Im-
age.
2.7. Immuno£uorescent microscopy
HeLa cells expressing mitochondrial matrix-targeted green £uores-
cent protein (GFP) were seeded onto slides and grown to V50%
con£uence in Dulbecco’s modi¢ed Eagle’s serum and permeabilized
by addition of acetone for 10 min. Cells were then incubated with
Alexa Fluor 594-conjugated anti-PDH E2 for 1 h (Molecular Probes).
Slides were viewed on an Axioscope 2 microscope with Attoarc HBO
150 W mercury lamp.
3. Results
The quantitation described here depends on having mAbs
highly speci¢c to the proteins of interest. In the cases of PDH
and complex III, we have produced several such mAbs, and
for Western blotting chose a mAb against the E1K subunit
and core protein 2 respectively. These mAbs show only a
single band on SDS^PAGE gels of whole mitochondria
from heart, and one band with either mitochondria or whole
cell extracts of ¢broblast and HeLa cell lines [19]. To comple-
ment the chosen mAbs, the two proteins (PDH E1K and com-
plex III core 2) were puri¢ed after over-expression in E. coli.
Each of these ran as a single band.
3.1. The ratio of complex III to PDH is around 200:1
in human heart mitochondria
Fig. 1 shows a typical experiment in which accurately de-
termined amounts of heart mitochondrial protein were sub-
jected to electrophoresis, and subsequent blotting and detec-
tion in the same gel as a range of concentrations of puri¢ed
E1K of PDH and core 2 of complex III. In this way, the
experimental and control samples were treated equally
throughout the entire procedure. Conventional Western blot-
ting methods utilize a catalytic reaction by an enzyme-coupled
antibody complex for detection. Here, we incubated the blots
with primary mAbs and then in a secondary reaction with an
anti-mouse mAb, which was labeled directly with the £uores-
cent dye Alexa Fluor 488, as a reporter group. In heart mi-
tochondria, values of 80T 34 pmol/mg and 270T72 pmol/mg
were obtained for the E1K subunit of PDH and core 2 protein
respectively. The large variation in values for each protein is
probably due to the variability in purity and integrity of the
organelle in di¡erent mitochondrial preparations. E1K is
present in 60 copies per PDH complex monomer [8]. Complex
III is composed of 11 di¡erent subunits with core 2 present
in one copy per monomer [10]. Thus, the ratio of PDH to
complex III in human heart mitochondria is 1:202, see
Table 1.
Fig. 2. Immunolabeling of heart ultrathin cryosections. A: Ultrathin cryosection labeled with anti-PDH E2 mAb and 5 nm Au-conjugated
GAM secondary antibody. Note multi-particle label clusters (circled). B: Anti-complex III core 2 mAb, 5 nm Au GAM secondary. All size
bars 100 nm.
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3.2. In human cells from tissue culture, the ratio of complex III
to PDH is around 100:1
Also determined were the levels of PDH to complex III in
MRC ¢broblast mitochondria and in HeLa cells. In both of
these cell lines, there are much lower amounts of these two
complexes than in heart mitochondria on a per mg protein
basis. Thus, ¢broblast mitochondria and HeLa whole cell ex-
tracts have around 27-fold and 80-fold less complex III re-
spectively than heart tissue.
The ratio of PDH to complex III was approximately 1:128
for ¢broblast mitochondria and 1:100 in HeLa cells. In one
set of experiments, the levels of complex III and PDH were
measured in Rho0 MRC5 ¢broblast mitochondria, isolated
from cells in which mtDNA had been depleted by EtBr treat-
ment. Such cells are a useful model for mtDNA depletion
syndrome, one of many pathological conditions caused by a
genetic alteration of mitochondrial biogenesis [20]. In Rho0
cells the level of core 2 was only 35% of untreated cells. How-
ever, depletion of mtDNA did not alter the levels of PDH.
3.3. Immunoelectron microscopy to detect levels of complex III
and PDH
The same mAb used in Western analysis for quanti¢cation
of core protein 2 gave good immunolabeling of ultrathin heart
cryosections as shown in Fig. 2A. For reaction with PDH, a
mAb against the E2 subunit proved superior to the E1K sub-
unit mAb and was used instead (Fig. 2B). For both com-
plexes, several sections were ¢xed, reacted with primary
mAb and then labeled with secondary antibody with attached
5 nm gold particles.
As evident in Fig. 2B, core 2 protein is distributed relatively
evenly through the sections along the clearly observed mito-
chondrial cristal membrane. By contrast, the E2 subunit of
PDH appears as irregularly distributed clusters of two to six
gold particles in the space between these membranes. The
density of labeling was 80 particles/Wm2 and 364 particles/
Wm2 for PDH E2 and core 2 respectively. Accounting for 60
copies of E2 per PDH enzyme, this represents an enzyme ratio
of 1:273 for PDH:complex III, which is in the same range
found by Western blot quanti¢cation in heart mitochondria.
3.4. Fluorescence imaging of PDH distribution
HeLa cells expressing a mitochondrial matrix-targeted GFP
[21] show £uorescent green labeling throughout the entire
mitochondrion, which extends under some conditions as a
¢lamentous network through the cell. As shown in Fig. 3A,
PDH labeled red with the E2-reactive mAb is distributed
punctately along this reticulum (yellow spots due to super-
imposition of the red mAb on the green GFP). Fragmentation
of the reticulum, as shown in Fig. 3B, generates a large num-
ber of small ovoid mitochondria with at least one, and usually
several PDH complexes in each.
4. Discussion
A full description of the protein content of a cell requires
both identi¢cation of all gene products expressed, including
post-translationally modi¢ed forms, and estimates of the
amounts of each over a range of times and cellular conditions.
Here, we have examined the cellular content of two proteins,
Fig. 3. Fluorescence microscopy of HeLa cells. A: Merged image of HeLa cell mitochondrial reticulum of HeLa cell visualized by mitochon-
drial matrix-targeted GFP (green) and PDH visualized by immunolabeling with Alexa Fluor 598-conjugated anti-PDH E2 mAb (yellow). Note
punctate PDH labeling. B: Fragmented mitochondria of HeLa cell visualized as in A. Size bars 2 Wm.
Table 1
Quanti¢cation of PDH (E1K) and complex III (core 2) in heart and cultured cell mitochondria and also in whole HeLa cell lysate
PDH E1K (pmol/mg) Complex III core 2 (pmol/mg) Ratio PDH/complex III core 2
Heart mitochondria 80T 34 (8) 270T 72 (6) 1:202
MRC5 mitochondria 4.7 T 2.1 (4) 10T 1.8 (7) 1:128
MRC5 Rho0 mitochondria 5.7 T 3.1 (4) 3.6 T 1.4 (7) 1:38
HeLa cell extract 2.0 T 1.0 (11) 3.3 T 1.2 (11) 1:100
The mean concentrationsT S.D. of E1K and core 2 proteins are shown. The enzyme ratio is determined by this concentration and the stoichio-
metric subunit composition of these enzymes, i.e. 60 E1K proteins/PDH enzyme and one core 2 protein/complex III.
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PDH and complex III of mitochondria, by a novel Western
blotting approach that uses highly speci¢c mAbs to these
proteins and puri¢ed antigen proteins for calibration. The
secondary mAb used in the quantitative detection is conju-
gated directly with Alexa Fluor dye, which has a high quan-
tum yield and, therefore, does not require enzymatic ampli¢-
cation to generate su⁄cient signal.
We ¢nd that the levels of complex III (and PDH) are 27
times higher in human heart mitochondria on a per mg of
total protein basis than in the organelle isolated from the
primary cell line MRC lung ¢broblasts and 80-fold higher
than in whole cell extracts from the transformed cell line
HeLa. This is expected because heart mitochondria are speci-
alized for producing high levels of ATP to fuel the contractile
function of this tissue and are enriched in cristal membrane
[22], the site of OXPHOS enzymes. Cells in tissue culture, in
contrast, produce most of their energy by glycolysis rather
than OXPHOS [12,23]. Such cells typically show many fewer
cristae per unit volume than heart mitochondria [20].
Signi¢cantly, there is a change in the ratio of PDH to com-
plex III. In heart cells, this ratio is 1:202, while in ¢broblast
mitochondria and HeLa cells it is 1:128 and 1:100 respec-
tively. The implication is that the levels of PDH and complex
III are di¡erently regulated at the expression or translational
level in response to energy substrate supply and cellular ATP
needs. When mitochondrial DNA is depleted from ¢broblast
cells by EtBr, a functional complex III is no longer assembled
because the mitochondrially encoded cytochrome b is no lon-
ger synthesized. As a result, the steady-state levels of core 2
were reduced by two thirds. However, the levels of PDH were
unaltered, indicating that expression of PDH is not linked to
mtDNA levels.
It is interesting to convert the concentration of various
proteins in a cell into copy number, which can be done for
HeLa cells, where we measured enzyme concentrations in
whole cell extracts obtained from a known number of cells.
There are around 15 000 copies of PDH and 1.5 million copies
of complex III in these cells. This compares with a copy num-
ber of mtDNA of 1000^5000 [24,25] (a value that remains to
be determined accurately).
Recent studies have established that mitochondria are pleo-
morphic [26]. In di¡erentiated heart tissue, there are large
individual mitochondria lying along and within the contractile
elements. In cell culture, the organelle can exist as a continu-
ous reticulum or as thousands of ovoid mitochondria, depend-
ing on the cell cycle stage [26]. These variations of morphol-
ogy are evident in EM, as well as light microscopy when the
organelle is labeled by the £uorescent GFPs. Here, we have
examined the distribution of PDH and complex III within
mitochondria by these techniques. The two complexes were
immunolabeled for EM using speci¢c mAbs and secondary
antibodies with 5 nm gold particles attached. In sections of
heart tissue, complex III was evenly distributed within the
organelle, predominantly on cristal membranes while PDH
was clearly in the matrix space between cristae. The labeling
e⁄ciency of proteins in immunoelectron microscopy is low
due to inaccessibility of epitopes to the primary antibody in
the embedded section and also steric hindrance to the reaction
of the second antibody [27]. However, the fact that the ratio
of PDH to complex III determined by immunogold labeling is
273:1, similar to the 202:1 determined in Western blots, sug-
gests that the accessibility of epitopes for their respective
mAbs in the two complexes is nearly identical. The pattern
of gold particles is not a true re£ection of the density of
distribution of complex III for the reasons above. The distri-
bution of PDH seen in the EM pictures may be more repre-
sentative because each complex has 60 possible antibody bind-
ing sites. The circles drawn in Fig. 2 de¢ne the size of one
PDH complex with mAbs attached (the PDH complex itself
has a diameter of 210 AU [28], each mAb is about 100 AU long).
It can be seen that the PDH is labeled by clusters of two to six
gold particles, indicating that the e⁄ciency of labeling in the
EM section is greater than the 1.7% at which each complex
will bind one or less mAb. From Fig. 2, the distance between
PDH complexes is calculated to be 0.15 Wm.
Individual complex III molecules are not su⁄ciently dis-
persed to be resolved by light microscopy, and Alexa Fluor
594-labeled mAbs to core protein 2 give a continuous staining
of the entire mitochondrial network (result not shown). This is
not the case for PDH, which is stained punctately by speci¢c
mAbs. Based on data such as in Fig. 3, the average distance
between each complex is 0.24 Wm. As evident in Fig. 3B, each
ovoid organelle would receive multiple PDH complexes under
conditions where the mitochondrial reticulum becomes frag-
mented. From this and other data, the picture is emerging in
which the fusion and ¢ssion of mitochondria involves a ‘re-
peating unit’ that contains at least one nucleoid (one to three
copies of mtDNA and associated proteins) along with multi-
ple OXPHOS complexes and several PDH complexes [29].
Whether the mitochondrion is functionally homogeneous or
heterogeneous when reticular or fragmented remains to be
determined.
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